Growth Metrics

CapsoVision (CV) Assets (2024 - 2025)

CapsoVision recorded quarterly Assets of $18.2 million in Q4 2025, down 29.22% quarter-over-quarter from $25.7 million in Q3 2025, and up 8.1% year-over-year from $16.8 million in Q4 2024.

CapsoVision's Assets history runs 2 years deep, the most recent figure standing at $18.2 million for Q4 2025.

  • In Q4 2025, Assets rose 8.1% year-over-year to $18.2 million; the TTM figure through Dec 2025 stood at $18.2 million (up 8.1% YoY), while the FY2025 annual figure was $18.2 million, up 8.1% from the prior year.
  • Assets came in at $18.2 million for Q4 2025 at CapsoVision, down from $25.7 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $25.7 million in Q3 2025 to a low of $9.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 46.29 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 37.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 10.74 Bn
10 CapsoVision 167.59 Mn 157.48 Mn 1.95 Mn 18.16 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 18.16 Mn
Sep 30, 2025 25.66 Mn
Jun 30, 2025 9.55 Mn
Dec 31, 2024 16.80 Mn